Legend Biotech Newsroom

JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG

Seeking AlphaNov 25 13:58 ET

JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas

Seeking AlphaNov 19 11:06 ET

Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA

Seeking AlphaNov 18 10:07 ET

Morgan Stanley Maintains Legend Biotech(LEGN.US) With Buy Rating, Cuts Target Price to $82

Moomoo NewsNov 15 08:31 ET · Ratings

Morgan Stanley Remains a Buy on Legend Biotech (LEGN)

TipRanksNov 15 08:17 ET · Ratings

Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Yahoo FinanceNov 15 08:12 ET

China Data Point to Gradual Improvement, but Tariff Risk Looms

WSJNov 15 01:29 ET

Hillhouse HHLR Q3 hold positions: Chinese concept stocks hold an absolute dominant position, and the total market value of hold positions grew by more than 10%!

①HHLR Advisors, a subsidiary of Hillhouse Capital, saw its total market cap of US stocks holding positions grow by over 10% in the third quarter, with 9 of the top ten heavy positions being Chinese concept stocks; ②HHLR Advisors continued to hold heavy positions in Chinese concept stocks in the third quarter, with the market cap of Chinese concept stocks increasing from 85% in the second quarter to 93% in the third quarter.

cls.cnNov 14 19:07 ET

Legend Biotech Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceNov 14 08:11 ET

Truist Financial Maintains Legend Biotech(LEGN.US) With Buy Rating

Moomoo NewsNov 14 07:34 ET · Ratings

Legend Biotech (LEGN) Gets a Buy From Truist Financial

TipRanksNov 14 07:19 ET · Ratings

Cantor Fitzgerald Maintains Legend Biotech(LEGN.US) With Buy Rating, Raises Target Price to $83

Moomoo NewsNov 13 14:31 ET · Ratings

Scotiabank Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $76

Moomoo NewsNov 13 12:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $73 Price Target

BenzingaNov 13 09:10 ET

Legend Biotech Analyst Ratings

BenzingaNov 13 09:09 ET · Ratings

A Quick Look at Today's Ratings for Legend Biotech(LEGN.US), With a Forecast Between $73 to $94

Moomoo NewsNov 13 08:00 ET · Ratings

Legend Biotech's CARVYKTI Advances and Strategic Positioning Amid Financial Resilience

TipRanksNov 13 06:27 ET

Analysts Offer Insights on Healthcare Companies: TScan Therapeutics (TCRX), Legend Biotech (LEGN) and ICU Medical (ICUI)

TipRanksNov 13 05:11 ET · Ratings

Express News | Legend Biotech Corp : Piper Sandler Cuts Target Price to $78 From $90

ReutersNov 13 00:18 ET

Genscript Reports on Legend Biotech's Q3 Financials

TipRanksNov 12 17:18 ET